— GLP-1 / GIP / GCGR Tri-Agonist
Retatrutide

Next-generation tri-agonist driving the new wave of metabolic studies.
Retatrutide is an investigational tri-agonist research peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. A leading subject of emerging metabolic literature; available in 5mg and 15mg research-grade lyophilized vials.
Spec
5mg / 15mg - Lyophilized
Mass
5.11-15.08 mg
Purity
99.5%
Triple incretin pathway co-activation; elevated metabolic modulation potential versus dual agonists.
Reconstitute with 2 mL bacteriostatic water for a 2.5-7.5 mg/mL concentration depending on vial size.
Store lyophilized at -20 deg C. Reconstituted material is stable at 2-8 deg C for 28 days.
Select SKU
Price · Per Vial
$24.00
5mg
Research & Operations
Frequently Asked Questions
Clinical-grade answers to the questions that matter most in advanced research procurement.